Seguir
Michael Rowley
Michael Rowley
Medicinal Chemistry Consultant, Xelaro Ltd
Dirección de correo verificada de mrowley.com - Página principal
Título
Citado por
Citado por
Año
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection
V Summa, A Petrocchi, F Bonelli, B Crescenzi, M Donghi, M Ferrara, ...
Journal of medicinal chemistry 51 (18), 5843-5855, 2008
7492008
Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in …
P Jones, S Altamura, J Boueres, F Ferrigno, M Fonsi, C Giomini, ...
Journal of medicinal chemistry 52 (22), 7170-7185, 2009
3602009
MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants
V Summa, SW Ludmerer, JA McCauley, C Fandozzi, C Burlein, G Claudio, ...
Antimicrobial agents and chemotherapy 56 (8), 4161-4167, 2012
3032012
Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase
L Tomei, S Altamura, L Bartholomew, A Biroccio, A Ceccacci, L Pacini, ...
Journal of virology 77 (24), 13225-13231, 2003
2412003
Fluorination of 3-(3-(piperidin-1-yl) propyl) indoles and 3-(3-(piperazin-1-yl) propyl) indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles
MB van Niel, I Collins, MS Beer, HB Broughton, SKF Cheng, ...
Journal of medicinal chemistry 42 (12), 2087-2104, 1999
2351999
Current and novel approaches to the drug treatment of schizophrenia
M Rowley, LJ Bristow, PH Hutson
Journal of medicinal chemistry 44 (4), 477-501, 2001
2112001
Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site
S Di Marco, C Volpari, L Tomei, S Altamura, S Harper, F Narjes, U Koch, ...
Journal of Biological Chemistry 280 (33), 29765-29770, 2005
2052005
Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor
S Harper, JA McCauley, MT Rudd, M Ferrara, M DiFilippo, B Crescenzi, ...
ACS medicinal chemistry letters 3 (4), 332-336, 2012
2022012
3'-(Arylmethyl)-and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2 (1H)-ones: orally active antagonists of the glycine site on the NMDA receptor
JJ Kulagowski, R Baker, NR Curtis, IM Mawer, AM Moseley, MP Ridgill, ...
Journal of medicinal chemistry 37 (10), 1402-1405, 1994
1721994
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists
M Rowley, JJ Kulagowski, AP Watt, D Rathbone, GI Stevenson, ...
Journal of medicinal chemistry 40 (25), 4053-4068, 1997
1711997
Niraparib: a poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of tumors with defective homologous recombination
P Jones, K Wilcoxen, M Rowley, C Toniatti
Journal of medicinal chemistry 58 (8), 3302-3314, 2015
1692015
3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonists
M Rowley, DJ Hallett, S Goodacre, C Moyes, J Crawforth, TJ Sparey, ...
Journal of medicinal chemistry 44 (10), 1603-1614, 2001
1672001
3-Heteroaryl-2-pyridones: Benzodiazepine site ligands with functional selectivity for α2/α3-subtypes of human GABAA receptor-ion channels
I Collins, C Moyes, WB Davey, M Rowley, FA Bromidge, K Quirk, JR Atack, ...
Journal of medicinal chemistry 45 (9), 1887-1900, 2002
1592002
5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl) piperidin-4-yl) isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors
M Rowley, HB Broughton, I Collins, R Baker, F Emms, R Marwood, ...
Journal of medicinal chemistry 39 (10), 1943-1945, 1996
1591996
Total synthesis of (+)-ophiobolin C
M Rowley, M Tsukamoto, Y Kishi
Journal of the American Chemical Society 111 (7), 2735-2737, 1989
1591989
4,5-Dihydroxypyrimidine Carboxamides and N-Alkyl-5-hydroxypyrimidinone Carboxamides Are Potent, Selective HIV Integrase Inhibitors with Good …
V Summa, A Petrocchi, VG Matassa, C Gardelli, E Muraglia, M Rowley, ...
Journal of medicinal chemistry 49 (23), 6646-6649, 2006
1472006
Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase
S Harper, S Avolio, B Pacini, M Di Filippo, S Altamura, L Tomei, ...
Journal of medicinal chemistry 48 (14), 4547-4557, 2005
1332005
Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors
P Pace, ME Di Francesco, C Gardelli, S Harper, E Muraglia, E Nizi, ...
Journal of Medicinal Chemistry 50 (9), 2225-2239, 2007
1242007
Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases
P Jones, S Altamura, R De Francesco, P Gallinari, A Lahm, ...
Bioorganic & medicinal chemistry letters 18 (6), 1814-1819, 2008
1232008
3-Acyl-4-hydroxyquinolin-2 (1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex
M Rowley, PD Leeson, GI Stevenson, AM Moseley, I Stansfield, ...
Journal of medicinal chemistry 36 (22), 3386-3396, 1993
1201993
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20